| Bethanie B Sorensen, PA-C | |
|
10815 W Mcdowell Rd Ste 202, Avondale, AZ 85392-5010 | |
| (623) 433-0202 | |
| (623) 433-0204 |
| Full Name | Bethanie B Sorensen |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 21 Years |
| Location | 10815 W Mcdowell Rd Ste 202, Avondale, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396747044 | NPI | - | NPPES |
| Z145996 | Other | MEDICARE | |
| 832693 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 2906 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| La Paz Regional Hospital | Parker, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Medical Services Inc | 1052328408 | 74 |
News Archive
Intravenous (I.V.) iron treatment with ferric carboxymaltose to reverse iron deficiency can significantly improve symptoms, exercise tolerance and quality of life for chronic heart failure (CHF) patients, researchers said in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.
Pfizer Inc. issued the following statement in response to today's discussion by the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) regarding the use of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine)in adults 50 years of age and older.
Directly activating a gene important to exciting our excitatory neurons and associated with major depression may help turn around classic symptoms like social isolation and loss of interest, at least for males, scientists report.
Impax Laboratories (Netherlands) B.V., a wholly owned subsidiary of Impax Laboratories, Inc. today announced that it has submitted a Marketing Authorization Application for IPX066 to the European Medicines Agency. IPX066 is an investigational extended-release capsule formulation of carbidopa-levodopa for the treatment of idiopathic Parkinson's disease.
Results of the TRANSFORMS and FREEDOMS studies, the two pivotal Phase III clinical trials with oral FTY720 (fingolimod), have been published in The New England Journal of Medicine, providing comprehensive evidence to support the efficacy and safety profile of this first-in-class therapy for multiple sclerosis (MS).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bethanie B Sorensen, PA-C 3815 E Bell Rd Ste 2200, Phoenix, AZ 85032-2139 Ph: (602) 633-3838 | Bethanie B Sorensen, PA-C 10815 W Mcdowell Rd Ste 202, Avondale, AZ 85392-5010 Ph: (623) 433-0202 |
News Archive
Intravenous (I.V.) iron treatment with ferric carboxymaltose to reverse iron deficiency can significantly improve symptoms, exercise tolerance and quality of life for chronic heart failure (CHF) patients, researchers said in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.
Pfizer Inc. issued the following statement in response to today's discussion by the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) regarding the use of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine)in adults 50 years of age and older.
Directly activating a gene important to exciting our excitatory neurons and associated with major depression may help turn around classic symptoms like social isolation and loss of interest, at least for males, scientists report.
Impax Laboratories (Netherlands) B.V., a wholly owned subsidiary of Impax Laboratories, Inc. today announced that it has submitted a Marketing Authorization Application for IPX066 to the European Medicines Agency. IPX066 is an investigational extended-release capsule formulation of carbidopa-levodopa for the treatment of idiopathic Parkinson's disease.
Results of the TRANSFORMS and FREEDOMS studies, the two pivotal Phase III clinical trials with oral FTY720 (fingolimod), have been published in The New England Journal of Medicine, providing comprehensive evidence to support the efficacy and safety profile of this first-in-class therapy for multiple sclerosis (MS).
› Verified 1 days ago
Eric Tomas Ovalle, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3125 N Dysart Rd, Avondale, AZ 85392 Phone: 602-726-8788 Fax: 480-420-0732 | |
Olivia Abuhl, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 235 W Western Ave, Avondale, AZ 85323 Phone: 602-230-7373 Fax: 602-230-3086 | |
Mr. Robert T Davis, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 13065 W Mcdowell Rd Ste A107, Phoenix Gi Consultants, Avondale, AZ 85392 Phone: 623-907-8686 | |
Michelle D Howland, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 13065 W Mcdowell Rd Ste C130, Avondale, AZ 85392 Phone: 623-932-5042 Fax: 623-846-7575 | |
Lauren Rae Yanez, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 10815 W Mcdowell Rd Ste 301, Avondale, AZ 85392 Phone: 623-535-0740 Fax: 623-535-0741 | |
Rick M Olesinski, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 10450 W Mcdowell Rd Ste 102, Avondale, AZ 85392 Phone: 602-648-5444 Fax: 602-772-3804 | |
Dustin Marley, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 13055 W Mcdowell Rd, Building E, Ste 109, Avondale, AZ 85392 Phone: 888-220-6432 |